Learn More
Kluwer. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDervis License, which permits use, distribution , and reproduction in any medium, provided that the Contribution is properly cited, the use is noncommercial, and no modifications or adaptations are made.
*Chair of 2004 Writing Committee; †Recused from voting on Section 8: Anticoagulants as Ancillary Therapy and Section 10: Anticoagulants; ‡Recused from voting on Section 5: Facilitated PCI; §Canadian Cardiovascular Society Representative; American Academy of Family Physicians Representative; ¶American College of Physicians Representative; **Recused from(More)
BACKGROUND The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock. METHODS Patients with shock due to left ventricular failure complicating myocardial infarction were randomly assigned to emergency(More)
CONTEXT Enoxaparin has demonstrated advantages over unfractionated heparin in low- to moderate-risk patients with non-ST-segment elevation acute coronary syndromes (ACS) treated with a conservative strategy. OBJECTIVES To compare the outcomes of patients treated with enoxaparin vs unfractionated heparin and to define the role of enoxaparin in patients(More)
ACCF/AHA TAsk ForCe MeMbers Jeffrey L. Anderson, MD, FACC, FAHA, Chair; Jonathan L. Halperin, MD, FACC, FAHA, Chair-elect; Nancy M. Albert, PhD, CCNs, CCrN; biykem bozkurt, MD, PhD, FACC, FAHA; ralph G. brindis, MD, MPH, MACC; Lesley H. Curtis, PhD; David DeMets, PhD; robert A. Guyton, MD, FACC; Judith s. Hochman, MD, FACC, FAHA; richard J. kovacs, MD,(More)
(Circulation. 2014;129[suppl 2]:S102-S138) © 2013 the expert Panel Members. Circulation is published on behalf of the American heart Association, Inc., by Wolters Kluwer; the Journal of the American College of Cardiology is published on behalf of the American College of Cardiology Foundation by elsevier Inc.; Obesity is published on behalf of the obesity(More)